Exercise of options against Surgical Science’s two largest shareholders
Surgical Science has been informed that Jeff Berkley, founder of Mimic Technologies and the largest shareholder in the company when Surgical Science acquired it in January 2021, has called on 119,982 call options from Surgical Science's two main shareholders.
In January 2021, Surgical Science announced that the company had entered into an agreement to acquire Mimic Technologies, an American company with operations in robotic surgery. The sellers were approximately 10 shareholders, of which Jeff Berkley was the largest shareholder with about 40 percent of the company.
As part of the acquisition, Jeff Berkley invested in 169,800 shares in Surgical Science. These were issued at a subscription price of SEK 98.30, corresponding to the subscription price in the directed share issue that was carried out to finance the acquisition.
Surgical Science has today been informed that the company's two main owners, Jan Bengtsson and Roland Bengtsson, in connection with the acquisition, also issued 119,982 call options from their own holdings to Jeff Berkley. This means that the options do not entail any dilution for other shareholders upon exercise. The exercise price of the options was set at SEK 120.00 and the exercise period was 20 December 2023 to 20 January 2024.
Jeff Berkley has called for exercise of these options. The sale is reported by Jan Bengtsson through the company Marknadspotential AB and Roland Bengtsson through the company Semelin Kapitalförvaltning AB to the Swedish Financial Supervisory Authority.
Gothenburg, Sweden, January 15, 2024
Surgical Science Sweden AB (publ)
This press release, in its entirety, is available through the attachment or via:
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.